Immunological Medicines for Poultry
Immunological veterinary medicinal products, including vaccines, are authorised for poultry.
Name
|
Description
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Animal
|
Further Information
|
Vaxxitek HVT + IBD
|
Infektiöse Bursitis,
Marek'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/02/032/001 |
13.08.2002 |
Huhn |
EPAR: Vaxxitek HVT + IBD
|
Avinew
|
Newcastle-Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.02053.01.1 |
05.03.2002 |
Huhn |
PharmNet.Bund
|
Avinew NEO
|
Newcastle-Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.02053.02.1 |
30.07.2020 |
Huhn, Pute |
PharmNet.Bund
|
Dindoral SPF
|
Infektiöse Hämorrhagische Enteritis
|
Boehringer Ingelheim Vetmedica GmbH
|
5a/95 |
22.07.1996 |
Pute |
PharmNet.Bund
|
Terivac
|
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
106a/90 |
18.11.1998 |
Pute |
PharmNet.Bund
|
Gallimune 407 ND+IB+EDS+ART
|
Newcastle-Krankheit, Infektiöse Bronchitis, Egg Drop-Syndrom, Aviäre Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.01043.01.1 |
11.05.2000 |
Huhn |
PharmNet.Bund
|
Parvokan
|
Parvovirose der Moschusenten,
Derzsysche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.01012.01.1 |
06.05.2004 |
Moschusente |
PharmNet.Bund
|
Palmivax
|
Parvovirushepatitis
|
Boehringer Ingelheim Vetmedica GmbH
|
44a/83 |
21.06.2000 |
Gans, Moschusente |
PharmNet.Bund
|
Trituren
|
Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
38a/92 |
27.12.1994 |
Pute |
PharmNet.Bund
|
Gallimune 303 ND+IB+ART
|
Newcastle-Krankheit, Infektiöse Bronchitis, Aviäre Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.01041.01.1 |
15.05.2000 |
Huhn |
PharmNet.Bund
|
HatchPak Avinew
|
Newcastle-Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.03614.01.1 |
27.05.2008 |
Huhn |
PharmNet.Bund
|
Gallimune 302 ND+IB+EDS
|
Newcastle-Krankheit, Infektiöse Bronchitis, Egg Drop-Syndrom
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.01042.01.1 |
15.05.2000 |
Huhn |
PharmNet.Bund
|
Gallimune Se + St
|
Salmonellen-Infektion
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.03348.01.1 |
15.06.2007 |
Huhn |
PharmNet.Bund
|
Gallivac IB88
|
Infektiöse Bronchitis
|
Boehringer Ingelheim Vetmedica GmbH
|
230a/97 |
17.06.1999 |
Huhn |
PharmNet.Bund
|
HatchPak IB H120 NEO
|
Infektiöse Bronchitis
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.03472.01.2 |
17.02.2017 |
Huhn |
PharmNet.Bund
|
Gallivac IB88 Neo
|
Infektiöse Bronchitis
|
Boehringer Ingelheim Vetmedica GmbH
|
230a/97-1 |
26.06.2015 |
Huhn |
PharmNet.Bund
|
Nemovac
|
Infektiöse Rhinotracheitis
|
Boehringer Ingelheim Vetmedica GmbH
|
PEI.V.04331.01.1 |
27.05.2008 |
Huhn |
PharmNet.Bund
|
PREVEXXION RN+HVT
|
Marek'sche Krankheit
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/23/302 |
26.10.2023 |
Huhn |
EPAR: PREVEXXION RN+HVT
|
CEVAC IBird
|
Infektiöse Bronchitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11646.01.1 |
20.06.2013 |
Huhn |
PharmNet.Bund
|
Cevac Salmovac
|
Salmonellen-Infektion
|
Ceva Tiergesundheit GmbH
|
PEI.V.02823.01.1 |
07.11.2002 |
Huhn |
PharmNet.Bund
|
Cevac Meta L
|
Aviäre Rhinotracheitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11806.01.1 |
31.10.2016 |
Huhn |
PharmNet.Bund
|
CEVAC TRANSMUNE
|
Infektiöse Bursitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11421.01.1 |
15.10.2010 |
Huhn |
PharmNet.Bund
|
Novamune
|
Infektiöse Bursitis
|
CEVA Tiergesundheit GmbH
|
PEI.V.11907.01.1 |
14.08.2018 |
Huhn |
PharmNet.Bund
|
CEVAC MASS L
|
Infektiöse Bronchitis
|
Ceva Tiergesundheit GmbH
|
PEI.V.11823.01.1 |
04.04.2016 |
Huhn |
PharmNet.Bund
|
Vectormune ND
|
Marek'sche Krankheit, Newcastle-Krankheit
|
CEVA-Phylaxia Co. Ltd., Ungarn
|
EU/2/15/188 |
08.09.2015 |
Huhn |
EPAR: Vectormune ND
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 520 in BAnz AT 22.08.2024 B6.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.